Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).
- The Silent Threat To Clinical Trials: Why Shelf-Life Management Can Determine Study Success
- CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture
- AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain
- Five Places Where AI Stalls In Clinical Supply
- ADC CDMO Selection For Small Biotech
- More Than Half The Drug We Make Never Reaches A Patient
- Lessons In Forecasting Discipline From A $40B Supply Chain
- Clinical Supply When There's No Drug To Ship
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
A Custom IRT System Facilitates Precision Medicine Studies
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
GMP Clinical Storage Strategies for Today's Complex Trials
Temperature‑sensitive therapies need more than basic freezer space. Purpose‑built GMP storage protects product integrity, supports compliance, and adds flexibility as trial complexity grows.
-
Distributing Clinical Supply In The EU For Compassionate Use Programs
Explore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.
-
Understanding Injectable Drug Container Closure Systems
Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
Why Advanced cGMP Manufacturing Is Key to Pharma Success
Advanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.
-
Overcome Vaccine Development Complexities With The Right Supply Chain Partner
Explore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
GxP Inventory Delivers Real-Time Visibility, Operational Efficiency
Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
- Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.